Medical Care
Global Lipid Nanoparticle CDMO Market Research Report 2025
- Mar 11, 25
- ID: 124070
- Pages: 98
- Figures: 94
- Views: 55
The global market for Lipid Nanoparticle CDMO was valued at US$ 6400 million in the year 2024 and is projected to reach a revised size of US$ 13760 million by 2031, growing at a CAGR of 11.5% during the forecast period.
A Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of lipid nanoparticles (LNPs). LNPs are used in various biomedical applications, particularly for drug delivery systems, including RNA-based therapies like mRNA vaccines. A lipid nanoparticle CDMO provides services ranging from the formulation of lipid nanoparticles to large-scale production, ensuring quality, scalability, and compliance with regulatory standards.
North American market for Lipid Nanoparticle CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lipid Nanoparticle CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lipid Nanoparticle CDMO in Gene Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lipid Nanoparticle CDMO include GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, Carcell, Croda International, Detai Biotechnology, Waters, MicroNano Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticle CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticle CDMO.
The Lipid Nanoparticle CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Nanoparticle CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid Nanoparticle CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript
Creative Biolabs
Merck
Cytiva
WuXi STA
Carcell
Croda International
Detai Biotechnology
Waters
MicroNano Biologics
Precigenome
Evonik
Avanti Polar Lipids
Genevant Sciences
Nippon Fine Chemical
Lipoid
Segment by Type
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Cationic Lipid-Nucleic Acid Complexes
Segment by Application
Gene Therapy
Vaccine Development
Cancer Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipid Nanoparticle CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A Contract Development and Manufacturing Organization (CDMO) that specializes in the development and production of lipid nanoparticles (LNPs). LNPs are used in various biomedical applications, particularly for drug delivery systems, including RNA-based therapies like mRNA vaccines. A lipid nanoparticle CDMO provides services ranging from the formulation of lipid nanoparticles to large-scale production, ensuring quality, scalability, and compliance with regulatory standards.
North American market for Lipid Nanoparticle CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lipid Nanoparticle CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lipid Nanoparticle CDMO in Gene Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lipid Nanoparticle CDMO include GenScript, Creative Biolabs, Merck, Cytiva, WuXi STA, Carcell, Croda International, Detai Biotechnology, Waters, MicroNano Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lipid Nanoparticle CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Nanoparticle CDMO.
The Lipid Nanoparticle CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lipid Nanoparticle CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid Nanoparticle CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript
Creative Biolabs
Merck
Cytiva
WuXi STA
Carcell
Croda International
Detai Biotechnology
Waters
MicroNano Biologics
Precigenome
Evonik
Avanti Polar Lipids
Genevant Sciences
Nippon Fine Chemical
Lipoid
Segment by Type
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Cationic Lipid-Nucleic Acid Complexes
Segment by Application
Gene Therapy
Vaccine Development
Cancer Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipid Nanoparticle CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid Nanoparticle CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solid Lipid Nanoparticles
1.2.3 Nanostructured Lipid Carriers
1.2.4 Cationic Lipid-Nucleic Acid Complexes
1.3 Market by Application
1.3.1 Global Lipid Nanoparticle CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Vaccine Development
1.3.4 Cancer Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid Nanoparticle CDMO Market Perspective (2020-2031)
2.2 Global Lipid Nanoparticle CDMO Growth Trends by Region
2.2.1 Global Lipid Nanoparticle CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lipid Nanoparticle CDMO Historic Market Size by Region (2020-2025)
2.2.3 Lipid Nanoparticle CDMO Forecasted Market Size by Region (2026-2031)
2.3 Lipid Nanoparticle CDMO Market Dynamics
2.3.1 Lipid Nanoparticle CDMO Industry Trends
2.3.2 Lipid Nanoparticle CDMO Market Drivers
2.3.3 Lipid Nanoparticle CDMO Market Challenges
2.3.4 Lipid Nanoparticle CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid Nanoparticle CDMO Players by Revenue
3.1.1 Global Top Lipid Nanoparticle CDMO Players by Revenue (2020-2025)
3.1.2 Global Lipid Nanoparticle CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Lipid Nanoparticle CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lipid Nanoparticle CDMO Revenue
3.4 Global Lipid Nanoparticle CDMO Market Concentration Ratio
3.4.1 Global Lipid Nanoparticle CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle CDMO Revenue in 2024
3.5 Global Key Players of Lipid Nanoparticle CDMO Head office and Area Served
3.6 Global Key Players of Lipid Nanoparticle CDMO, Product and Application
3.7 Global Key Players of Lipid Nanoparticle CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipid Nanoparticle CDMO Breakdown Data by Type
4.1 Global Lipid Nanoparticle CDMO Historic Market Size by Type (2020-2025)
4.2 Global Lipid Nanoparticle CDMO Forecasted Market Size by Type (2026-2031)
5 Lipid Nanoparticle CDMO Breakdown Data by Application
5.1 Global Lipid Nanoparticle CDMO Historic Market Size by Application (2020-2025)
5.2 Global Lipid Nanoparticle CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lipid Nanoparticle CDMO Market Size (2020-2031)
6.2 North America Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
6.4 North America Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid Nanoparticle CDMO Market Size (2020-2031)
7.2 Europe Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
7.4 Europe Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipid Nanoparticle CDMO Market Size (2020-2031)
8.2 Asia-Pacific Lipid Nanoparticle CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipid Nanoparticle CDMO Market Size (2020-2031)
9.2 Latin America Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
9.4 Latin America Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid Nanoparticle CDMO Market Size (2020-2031)
10.2 Middle East & Africa Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Lipid Nanoparticle CDMO Introduction
11.1.4 GenScript Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Lipid Nanoparticle CDMO Introduction
11.2.4 Creative Biolabs Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Lipid Nanoparticle CDMO Introduction
11.3.4 Merck Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Details
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Lipid Nanoparticle CDMO Introduction
11.4.4 Cytiva Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.4.5 Cytiva Recent Development
11.5 WuXi STA
11.5.1 WuXi STA Company Details
11.5.2 WuXi STA Business Overview
11.5.3 WuXi STA Lipid Nanoparticle CDMO Introduction
11.5.4 WuXi STA Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.5.5 WuXi STA Recent Development
11.6 Carcell
11.6.1 Carcell Company Details
11.6.2 Carcell Business Overview
11.6.3 Carcell Lipid Nanoparticle CDMO Introduction
11.6.4 Carcell Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.6.5 Carcell Recent Development
11.7 Croda International
11.7.1 Croda International Company Details
11.7.2 Croda International Business Overview
11.7.3 Croda International Lipid Nanoparticle CDMO Introduction
11.7.4 Croda International Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.7.5 Croda International Recent Development
11.8 Detai Biotechnology
11.8.1 Detai Biotechnology Company Details
11.8.2 Detai Biotechnology Business Overview
11.8.3 Detai Biotechnology Lipid Nanoparticle CDMO Introduction
11.8.4 Detai Biotechnology Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.8.5 Detai Biotechnology Recent Development
11.9 Waters
11.9.1 Waters Company Details
11.9.2 Waters Business Overview
11.9.3 Waters Lipid Nanoparticle CDMO Introduction
11.9.4 Waters Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.9.5 Waters Recent Development
11.10 MicroNano Biologics
11.10.1 MicroNano Biologics Company Details
11.10.2 MicroNano Biologics Business Overview
11.10.3 MicroNano Biologics Lipid Nanoparticle CDMO Introduction
11.10.4 MicroNano Biologics Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.10.5 MicroNano Biologics Recent Development
11.11 Precigenome
11.11.1 Precigenome Company Details
11.11.2 Precigenome Business Overview
11.11.3 Precigenome Lipid Nanoparticle CDMO Introduction
11.11.4 Precigenome Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.11.5 Precigenome Recent Development
11.12 Evonik
11.12.1 Evonik Company Details
11.12.2 Evonik Business Overview
11.12.3 Evonik Lipid Nanoparticle CDMO Introduction
11.12.4 Evonik Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.12.5 Evonik Recent Development
11.13 Avanti Polar Lipids
11.13.1 Avanti Polar Lipids Company Details
11.13.2 Avanti Polar Lipids Business Overview
11.13.3 Avanti Polar Lipids Lipid Nanoparticle CDMO Introduction
11.13.4 Avanti Polar Lipids Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.13.5 Avanti Polar Lipids Recent Development
11.14 Genevant Sciences
11.14.1 Genevant Sciences Company Details
11.14.2 Genevant Sciences Business Overview
11.14.3 Genevant Sciences Lipid Nanoparticle CDMO Introduction
11.14.4 Genevant Sciences Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.14.5 Genevant Sciences Recent Development
11.15 Nippon Fine Chemical
11.15.1 Nippon Fine Chemical Company Details
11.15.2 Nippon Fine Chemical Business Overview
11.15.3 Nippon Fine Chemical Lipid Nanoparticle CDMO Introduction
11.15.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.15.5 Nippon Fine Chemical Recent Development
11.16 Lipoid
11.16.1 Lipoid Company Details
11.16.2 Lipoid Business Overview
11.16.3 Lipoid Lipid Nanoparticle CDMO Introduction
11.16.4 Lipoid Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.16.5 Lipoid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid Nanoparticle CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solid Lipid Nanoparticles
1.2.3 Nanostructured Lipid Carriers
1.2.4 Cationic Lipid-Nucleic Acid Complexes
1.3 Market by Application
1.3.1 Global Lipid Nanoparticle CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Vaccine Development
1.3.4 Cancer Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid Nanoparticle CDMO Market Perspective (2020-2031)
2.2 Global Lipid Nanoparticle CDMO Growth Trends by Region
2.2.1 Global Lipid Nanoparticle CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lipid Nanoparticle CDMO Historic Market Size by Region (2020-2025)
2.2.3 Lipid Nanoparticle CDMO Forecasted Market Size by Region (2026-2031)
2.3 Lipid Nanoparticle CDMO Market Dynamics
2.3.1 Lipid Nanoparticle CDMO Industry Trends
2.3.2 Lipid Nanoparticle CDMO Market Drivers
2.3.3 Lipid Nanoparticle CDMO Market Challenges
2.3.4 Lipid Nanoparticle CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid Nanoparticle CDMO Players by Revenue
3.1.1 Global Top Lipid Nanoparticle CDMO Players by Revenue (2020-2025)
3.1.2 Global Lipid Nanoparticle CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Top Lipid Nanoparticle CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lipid Nanoparticle CDMO Revenue
3.4 Global Lipid Nanoparticle CDMO Market Concentration Ratio
3.4.1 Global Lipid Nanoparticle CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticle CDMO Revenue in 2024
3.5 Global Key Players of Lipid Nanoparticle CDMO Head office and Area Served
3.6 Global Key Players of Lipid Nanoparticle CDMO, Product and Application
3.7 Global Key Players of Lipid Nanoparticle CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipid Nanoparticle CDMO Breakdown Data by Type
4.1 Global Lipid Nanoparticle CDMO Historic Market Size by Type (2020-2025)
4.2 Global Lipid Nanoparticle CDMO Forecasted Market Size by Type (2026-2031)
5 Lipid Nanoparticle CDMO Breakdown Data by Application
5.1 Global Lipid Nanoparticle CDMO Historic Market Size by Application (2020-2025)
5.2 Global Lipid Nanoparticle CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lipid Nanoparticle CDMO Market Size (2020-2031)
6.2 North America Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
6.4 North America Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid Nanoparticle CDMO Market Size (2020-2031)
7.2 Europe Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
7.4 Europe Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipid Nanoparticle CDMO Market Size (2020-2031)
8.2 Asia-Pacific Lipid Nanoparticle CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipid Nanoparticle CDMO Market Size (2020-2031)
9.2 Latin America Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
9.4 Latin America Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid Nanoparticle CDMO Market Size (2020-2031)
10.2 Middle East & Africa Lipid Nanoparticle CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Lipid Nanoparticle CDMO Introduction
11.1.4 GenScript Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Lipid Nanoparticle CDMO Introduction
11.2.4 Creative Biolabs Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Lipid Nanoparticle CDMO Introduction
11.3.4 Merck Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Details
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Lipid Nanoparticle CDMO Introduction
11.4.4 Cytiva Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.4.5 Cytiva Recent Development
11.5 WuXi STA
11.5.1 WuXi STA Company Details
11.5.2 WuXi STA Business Overview
11.5.3 WuXi STA Lipid Nanoparticle CDMO Introduction
11.5.4 WuXi STA Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.5.5 WuXi STA Recent Development
11.6 Carcell
11.6.1 Carcell Company Details
11.6.2 Carcell Business Overview
11.6.3 Carcell Lipid Nanoparticle CDMO Introduction
11.6.4 Carcell Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.6.5 Carcell Recent Development
11.7 Croda International
11.7.1 Croda International Company Details
11.7.2 Croda International Business Overview
11.7.3 Croda International Lipid Nanoparticle CDMO Introduction
11.7.4 Croda International Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.7.5 Croda International Recent Development
11.8 Detai Biotechnology
11.8.1 Detai Biotechnology Company Details
11.8.2 Detai Biotechnology Business Overview
11.8.3 Detai Biotechnology Lipid Nanoparticle CDMO Introduction
11.8.4 Detai Biotechnology Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.8.5 Detai Biotechnology Recent Development
11.9 Waters
11.9.1 Waters Company Details
11.9.2 Waters Business Overview
11.9.3 Waters Lipid Nanoparticle CDMO Introduction
11.9.4 Waters Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.9.5 Waters Recent Development
11.10 MicroNano Biologics
11.10.1 MicroNano Biologics Company Details
11.10.2 MicroNano Biologics Business Overview
11.10.3 MicroNano Biologics Lipid Nanoparticle CDMO Introduction
11.10.4 MicroNano Biologics Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.10.5 MicroNano Biologics Recent Development
11.11 Precigenome
11.11.1 Precigenome Company Details
11.11.2 Precigenome Business Overview
11.11.3 Precigenome Lipid Nanoparticle CDMO Introduction
11.11.4 Precigenome Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.11.5 Precigenome Recent Development
11.12 Evonik
11.12.1 Evonik Company Details
11.12.2 Evonik Business Overview
11.12.3 Evonik Lipid Nanoparticle CDMO Introduction
11.12.4 Evonik Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.12.5 Evonik Recent Development
11.13 Avanti Polar Lipids
11.13.1 Avanti Polar Lipids Company Details
11.13.2 Avanti Polar Lipids Business Overview
11.13.3 Avanti Polar Lipids Lipid Nanoparticle CDMO Introduction
11.13.4 Avanti Polar Lipids Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.13.5 Avanti Polar Lipids Recent Development
11.14 Genevant Sciences
11.14.1 Genevant Sciences Company Details
11.14.2 Genevant Sciences Business Overview
11.14.3 Genevant Sciences Lipid Nanoparticle CDMO Introduction
11.14.4 Genevant Sciences Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.14.5 Genevant Sciences Recent Development
11.15 Nippon Fine Chemical
11.15.1 Nippon Fine Chemical Company Details
11.15.2 Nippon Fine Chemical Business Overview
11.15.3 Nippon Fine Chemical Lipid Nanoparticle CDMO Introduction
11.15.4 Nippon Fine Chemical Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.15.5 Nippon Fine Chemical Recent Development
11.16 Lipoid
11.16.1 Lipoid Company Details
11.16.2 Lipoid Business Overview
11.16.3 Lipoid Lipid Nanoparticle CDMO Introduction
11.16.4 Lipoid Revenue in Lipid Nanoparticle CDMO Business (2020-2025)
11.16.5 Lipoid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lipid Nanoparticle CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Solid Lipid Nanoparticles
Table 3. Key Players of Nanostructured Lipid Carriers
Table 4. Key Players of Cationic Lipid-Nucleic Acid Complexes
Table 5. Global Lipid Nanoparticle CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Lipid Nanoparticle CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Lipid Nanoparticle CDMO Market Share by Region (2020-2025)
Table 9. Global Lipid Nanoparticle CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Lipid Nanoparticle CDMO Market Share by Region (2026-2031)
Table 11. Lipid Nanoparticle CDMO Market Trends
Table 12. Lipid Nanoparticle CDMO Market Drivers
Table 13. Lipid Nanoparticle CDMO Market Challenges
Table 14. Lipid Nanoparticle CDMO Market Restraints
Table 15. Global Lipid Nanoparticle CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Lipid Nanoparticle CDMO Market Share by Players (2020-2025)
Table 17. Global Top Lipid Nanoparticle CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticle CDMO as of 2024)
Table 18. Ranking of Global Top Lipid Nanoparticle CDMO Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Lipid Nanoparticle CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Lipid Nanoparticle CDMO, Headquarters and Area Served
Table 21. Global Key Players of Lipid Nanoparticle CDMO, Product and Application
Table 22. Global Key Players of Lipid Nanoparticle CDMO, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Lipid Nanoparticle CDMO Revenue Market Share by Type (2020-2025)
Table 26. Global Lipid Nanoparticle CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Lipid Nanoparticle CDMO Revenue Market Share by Type (2026-2031)
Table 28. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Lipid Nanoparticle CDMO Revenue Market Share by Application (2020-2025)
Table 30. Global Lipid Nanoparticle CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Lipid Nanoparticle CDMO Revenue Market Share by Application (2026-2031)
Table 32. North America Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Lipid Nanoparticle CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 47. GenScript Company Details
Table 48. GenScript Business Overview
Table 49. GenScript Lipid Nanoparticle CDMO Product
Table 50. GenScript Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 51. GenScript Recent Development
Table 52. Creative Biolabs Company Details
Table 53. Creative Biolabs Business Overview
Table 54. Creative Biolabs Lipid Nanoparticle CDMO Product
Table 55. Creative Biolabs Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 56. Creative Biolabs Recent Development
Table 57. Merck Company Details
Table 58. Merck Business Overview
Table 59. Merck Lipid Nanoparticle CDMO Product
Table 60. Merck Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 61. Merck Recent Development
Table 62. Cytiva Company Details
Table 63. Cytiva Business Overview
Table 64. Cytiva Lipid Nanoparticle CDMO Product
Table 65. Cytiva Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 66. Cytiva Recent Development
Table 67. WuXi STA Company Details
Table 68. WuXi STA Business Overview
Table 69. WuXi STA Lipid Nanoparticle CDMO Product
Table 70. WuXi STA Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 71. WuXi STA Recent Development
Table 72. Carcell Company Details
Table 73. Carcell Business Overview
Table 74. Carcell Lipid Nanoparticle CDMO Product
Table 75. Carcell Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 76. Carcell Recent Development
Table 77. Croda International Company Details
Table 78. Croda International Business Overview
Table 79. Croda International Lipid Nanoparticle CDMO Product
Table 80. Croda International Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 81. Croda International Recent Development
Table 82. Detai Biotechnology Company Details
Table 83. Detai Biotechnology Business Overview
Table 84. Detai Biotechnology Lipid Nanoparticle CDMO Product
Table 85. Detai Biotechnology Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 86. Detai Biotechnology Recent Development
Table 87. Waters Company Details
Table 88. Waters Business Overview
Table 89. Waters Lipid Nanoparticle CDMO Product
Table 90. Waters Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 91. Waters Recent Development
Table 92. MicroNano Biologics Company Details
Table 93. MicroNano Biologics Business Overview
Table 94. MicroNano Biologics Lipid Nanoparticle CDMO Product
Table 95. MicroNano Biologics Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 96. MicroNano Biologics Recent Development
Table 97. Precigenome Company Details
Table 98. Precigenome Business Overview
Table 99. Precigenome Lipid Nanoparticle CDMO Product
Table 100. Precigenome Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 101. Precigenome Recent Development
Table 102. Evonik Company Details
Table 103. Evonik Business Overview
Table 104. Evonik Lipid Nanoparticle CDMO Product
Table 105. Evonik Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 106. Evonik Recent Development
Table 107. Avanti Polar Lipids Company Details
Table 108. Avanti Polar Lipids Business Overview
Table 109. Avanti Polar Lipids Lipid Nanoparticle CDMO Product
Table 110. Avanti Polar Lipids Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 111. Avanti Polar Lipids Recent Development
Table 112. Genevant Sciences Company Details
Table 113. Genevant Sciences Business Overview
Table 114. Genevant Sciences Lipid Nanoparticle CDMO Product
Table 115. Genevant Sciences Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 116. Genevant Sciences Recent Development
Table 117. Nippon Fine Chemical Company Details
Table 118. Nippon Fine Chemical Business Overview
Table 119. Nippon Fine Chemical Lipid Nanoparticle CDMO Product
Table 120. Nippon Fine Chemical Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 121. Nippon Fine Chemical Recent Development
Table 122. Lipoid Company Details
Table 123. Lipoid Business Overview
Table 124. Lipoid Lipid Nanoparticle CDMO Product
Table 125. Lipoid Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 126. Lipoid Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Lipid Nanoparticle CDMO Picture
Figure 2. Global Lipid Nanoparticle CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lipid Nanoparticle CDMO Market Share by Type: 2024 VS 2031
Figure 4. Solid Lipid Nanoparticles Features
Figure 5. Nanostructured Lipid Carriers Features
Figure 6. Cationic Lipid-Nucleic Acid Complexes Features
Figure 7. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Lipid Nanoparticle CDMO Market Share by Application: 2024 VS 2031
Figure 9. Gene Therapy Case Studies
Figure 10. Vaccine Development Case Studies
Figure 11. Cancer Treatment Case Studies
Figure 12. Lipid Nanoparticle CDMO Report Years Considered
Figure 13. Global Lipid Nanoparticle CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Lipid Nanoparticle CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Lipid Nanoparticle CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global Lipid Nanoparticle CDMO Market Share by Players in 2024
Figure 17. Global Lipid Nanoparticle CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Lipid Nanoparticle CDMO Revenue in 2024
Figure 19. North America Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 21. United States Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 25. Germany Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lipid Nanoparticle CDMO Market Share by Region (2020-2031)
Figure 33. China Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 41. Mexico Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 45. Turkey Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. GenScript Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 49. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 51. Cytiva Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 52. WuXi STA Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 53. Carcell Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 54. Croda International Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 55. Detai Biotechnology Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 56. Waters Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 57. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 58. Precigenome Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 59. Evonik Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 60. Avanti Polar Lipids Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 61. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 62. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 63. Lipoid Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Lipid Nanoparticle CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Solid Lipid Nanoparticles
Table 3. Key Players of Nanostructured Lipid Carriers
Table 4. Key Players of Cationic Lipid-Nucleic Acid Complexes
Table 5. Global Lipid Nanoparticle CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Lipid Nanoparticle CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Lipid Nanoparticle CDMO Market Share by Region (2020-2025)
Table 9. Global Lipid Nanoparticle CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Lipid Nanoparticle CDMO Market Share by Region (2026-2031)
Table 11. Lipid Nanoparticle CDMO Market Trends
Table 12. Lipid Nanoparticle CDMO Market Drivers
Table 13. Lipid Nanoparticle CDMO Market Challenges
Table 14. Lipid Nanoparticle CDMO Market Restraints
Table 15. Global Lipid Nanoparticle CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Lipid Nanoparticle CDMO Market Share by Players (2020-2025)
Table 17. Global Top Lipid Nanoparticle CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lipid Nanoparticle CDMO as of 2024)
Table 18. Ranking of Global Top Lipid Nanoparticle CDMO Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Lipid Nanoparticle CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Lipid Nanoparticle CDMO, Headquarters and Area Served
Table 21. Global Key Players of Lipid Nanoparticle CDMO, Product and Application
Table 22. Global Key Players of Lipid Nanoparticle CDMO, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lipid Nanoparticle CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Lipid Nanoparticle CDMO Revenue Market Share by Type (2020-2025)
Table 26. Global Lipid Nanoparticle CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Lipid Nanoparticle CDMO Revenue Market Share by Type (2026-2031)
Table 28. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Lipid Nanoparticle CDMO Revenue Market Share by Application (2020-2025)
Table 30. Global Lipid Nanoparticle CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Lipid Nanoparticle CDMO Revenue Market Share by Application (2026-2031)
Table 32. North America Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Lipid Nanoparticle CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Lipid Nanoparticle CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Lipid Nanoparticle CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Lipid Nanoparticle CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 47. GenScript Company Details
Table 48. GenScript Business Overview
Table 49. GenScript Lipid Nanoparticle CDMO Product
Table 50. GenScript Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 51. GenScript Recent Development
Table 52. Creative Biolabs Company Details
Table 53. Creative Biolabs Business Overview
Table 54. Creative Biolabs Lipid Nanoparticle CDMO Product
Table 55. Creative Biolabs Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 56. Creative Biolabs Recent Development
Table 57. Merck Company Details
Table 58. Merck Business Overview
Table 59. Merck Lipid Nanoparticle CDMO Product
Table 60. Merck Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 61. Merck Recent Development
Table 62. Cytiva Company Details
Table 63. Cytiva Business Overview
Table 64. Cytiva Lipid Nanoparticle CDMO Product
Table 65. Cytiva Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 66. Cytiva Recent Development
Table 67. WuXi STA Company Details
Table 68. WuXi STA Business Overview
Table 69. WuXi STA Lipid Nanoparticle CDMO Product
Table 70. WuXi STA Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 71. WuXi STA Recent Development
Table 72. Carcell Company Details
Table 73. Carcell Business Overview
Table 74. Carcell Lipid Nanoparticle CDMO Product
Table 75. Carcell Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 76. Carcell Recent Development
Table 77. Croda International Company Details
Table 78. Croda International Business Overview
Table 79. Croda International Lipid Nanoparticle CDMO Product
Table 80. Croda International Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 81. Croda International Recent Development
Table 82. Detai Biotechnology Company Details
Table 83. Detai Biotechnology Business Overview
Table 84. Detai Biotechnology Lipid Nanoparticle CDMO Product
Table 85. Detai Biotechnology Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 86. Detai Biotechnology Recent Development
Table 87. Waters Company Details
Table 88. Waters Business Overview
Table 89. Waters Lipid Nanoparticle CDMO Product
Table 90. Waters Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 91. Waters Recent Development
Table 92. MicroNano Biologics Company Details
Table 93. MicroNano Biologics Business Overview
Table 94. MicroNano Biologics Lipid Nanoparticle CDMO Product
Table 95. MicroNano Biologics Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 96. MicroNano Biologics Recent Development
Table 97. Precigenome Company Details
Table 98. Precigenome Business Overview
Table 99. Precigenome Lipid Nanoparticle CDMO Product
Table 100. Precigenome Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 101. Precigenome Recent Development
Table 102. Evonik Company Details
Table 103. Evonik Business Overview
Table 104. Evonik Lipid Nanoparticle CDMO Product
Table 105. Evonik Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 106. Evonik Recent Development
Table 107. Avanti Polar Lipids Company Details
Table 108. Avanti Polar Lipids Business Overview
Table 109. Avanti Polar Lipids Lipid Nanoparticle CDMO Product
Table 110. Avanti Polar Lipids Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 111. Avanti Polar Lipids Recent Development
Table 112. Genevant Sciences Company Details
Table 113. Genevant Sciences Business Overview
Table 114. Genevant Sciences Lipid Nanoparticle CDMO Product
Table 115. Genevant Sciences Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 116. Genevant Sciences Recent Development
Table 117. Nippon Fine Chemical Company Details
Table 118. Nippon Fine Chemical Business Overview
Table 119. Nippon Fine Chemical Lipid Nanoparticle CDMO Product
Table 120. Nippon Fine Chemical Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 121. Nippon Fine Chemical Recent Development
Table 122. Lipoid Company Details
Table 123. Lipoid Business Overview
Table 124. Lipoid Lipid Nanoparticle CDMO Product
Table 125. Lipoid Revenue in Lipid Nanoparticle CDMO Business (2020-2025) & (US$ Million)
Table 126. Lipoid Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Lipid Nanoparticle CDMO Picture
Figure 2. Global Lipid Nanoparticle CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lipid Nanoparticle CDMO Market Share by Type: 2024 VS 2031
Figure 4. Solid Lipid Nanoparticles Features
Figure 5. Nanostructured Lipid Carriers Features
Figure 6. Cationic Lipid-Nucleic Acid Complexes Features
Figure 7. Global Lipid Nanoparticle CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Lipid Nanoparticle CDMO Market Share by Application: 2024 VS 2031
Figure 9. Gene Therapy Case Studies
Figure 10. Vaccine Development Case Studies
Figure 11. Cancer Treatment Case Studies
Figure 12. Lipid Nanoparticle CDMO Report Years Considered
Figure 13. Global Lipid Nanoparticle CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Lipid Nanoparticle CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Lipid Nanoparticle CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global Lipid Nanoparticle CDMO Market Share by Players in 2024
Figure 17. Global Lipid Nanoparticle CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Lipid Nanoparticle CDMO Revenue in 2024
Figure 19. North America Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 21. United States Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 25. Germany Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lipid Nanoparticle CDMO Market Share by Region (2020-2031)
Figure 33. China Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 41. Mexico Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lipid Nanoparticle CDMO Market Share by Country (2020-2031)
Figure 45. Turkey Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Lipid Nanoparticle CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. GenScript Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 49. Creative Biolabs Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 51. Cytiva Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 52. WuXi STA Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 53. Carcell Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 54. Croda International Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 55. Detai Biotechnology Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 56. Waters Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 57. MicroNano Biologics Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 58. Precigenome Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 59. Evonik Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 60. Avanti Polar Lipids Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 61. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 62. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 63. Lipoid Revenue Growth Rate in Lipid Nanoparticle CDMO Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232